Clinical outcomes of agalsidase Beta (fabrazyme) in Chinese fabry disease patients with proteinuria: a case series - Quiz - MDSpire

Clinical outcomes of agalsidase Beta (fabrazyme) in Chinese fabry disease patients with proteinuria: a case series

  • By

  • Zelei He

  • Yuanyuan Wu

  • Hong Yang

  • Yijuan Li

  • Ling Xu

  • June 17, 2026

  • 0 min

Share

Original Source(s)

Clinical outcomes of agalsidase Beta (fabrazyme) in Chinese fabry disease patients with proteinuria: a case series

  • by Zelei He, Yuanyuan Wu, Hong Yang, Yijuan Li, Ling Xu

  • June 17, 2026

Related Content

The association of remnant cholesterol inflammatory index with the risk of major adverse cardiovascular events in patients with angina undergoing percutaneous coronary intervention: a retrospective study

Multitask Artificial Intelligence–Based Electrocardiogram Tool for Preoperative Cardiac Testing in Noncardiac Surgery: Retrospective Cohort Study of Health Care Utilization and Costs

Editorial: Environmental determinants of cardiovascular health: interactions with lifestyle and socioeconomic factors